Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin with Chemotherapy for Breast Cancer Brain Metastases
NCT00476827Phase 2Terminated
- Sponsor
- Duke University
- Start
- May 2007
- Primary completion
- May 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in breast cancer, sponsored by Duke University. Started May 2007; status: terminated.
02
Drugs
bevacizumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00476827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00476827.